A XM não fornece serviços a residentes nos Estados Unidos da América.

D
D

DSM

Notícias

Reuters - Há 4 semanas

Mara Files Second Ipr Petition In The Us

BRIEF-Mara Files Second Ipr Petition In The Us Aug 29 (Reuters) - MARA FILES SECOND INTER PARTES REVIEW (IPR) PETITION IN THE US CHALLENGING VALIDITY OF DSM PATENT: NO.10757959 “THRAUSTOCHYTRIDS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF.” Source text for Eikon: ID:nBw96wyMHa
D
Reuters - Há 5 meses

Firmenich Says Dimitri De Vreeze Will Be Firmenich CEO

BRIEF-DSM-Firmenich Says Dimitri De Vreeze Will Be DSM-Firmenich CEO May 8 (Reuters) - Dsm-Firmenich Ag DSFIR.AS : DSM-FIRMENICH LAUNCHES AS INNOVATORS IN NUTRITION, HEALTH, AND BEAUTY GERALDINE MATCHETT HAS DECIDED THIS IS RIGHT TIME TO FURTHER HER CAREER ELSEWHERE AND WILL MOVE ON, AS OF SEPTEMBER 1 DIMITRI DE VREEZE WILL BE DSM-FIRMENICH CEO. So
D
Reuters - Há 5 meses

Firmenich: Dimitri De Vreeze To Continue As Sole CEO, Ralf Schmeitz Appointed CFO

BRIEF-DSM-Firmenich: Dimitri De Vreeze To Continue As Sole CEO, Ralf Schmeitz Appointed CFO May 4 (Reuters) - DSM-FIRMENICH DSFIR.AS : EVOLUTION OF CEO STRUCTURE PER 1 SEPTEMBER, FOLLOWING COMPLETION OF THE MERGER CO-CEO STRUCTURE TO BE REPLACED BY SOLE CEO STRUCTURE DIMITRI DE VREEZE TO CONTINUE AS CEO AS GERALDINE MATCHETT DECIDED TO FURTHER HER
D
Reuters - Há 5 meses

DSM misses Q1 forecasts due to weak volumes and high costs

CORRECTED-UPDATE 2-DSM misses Q1 forecasts due to weak volumes and high costs Corrects company description in 5th paragraph May 2 (Reuters) - Dutch specialty chemicals maker DSM's DSMN.AS first-quarter profit and sales missed expectations on Tuesday, hit by weak volumes, persistently high inflation and low vitamin prices. DSM and Firmenich reported quarterly results separately for the last time ahead of the completion of their merger due next Monday.
D
G
S
Reuters - Há 5 meses

DSM reports first-quarter results below expectations

CORRECTED-DSM reports first-quarter results below expectations Corrects company description in 2nd paragraph May 2 (Reuters) - Dutch specialty chemicals maker DSM's DSMN.AS first-quarter core profit missed expectations on Tuesday as cost inflation remained elevated. The group, which makes vitamins and food supplements among others, reported quarterly core earnings (EBITDA) of 278 million euros ($305.36 million), below analysts' estimate of 280 million euros in a poll compiled by Vara Research.
D
Reuters - Há 5 meses

DSM Q1 Sales Down At EUR 1.89 Bln

BRIEF-DSM Q1 Sales Down At EUR 1.89 Bln May 2 (Reuters) - Koninklijke DSM NV DSMN.AS : Q1 SALES EUR 1.89 BILLION VERSUS EUR 2.01 BILLION YEAR AGO Q1 ADJUSTED EBITDA EUR 278 MILLION VERSUS EUR 367 MILLION YEAR AGO IT IS INTENDED THAT DSM-FIRMENICH WILL PROVIDE AN OUTLOOK FOR REMAINDER OF 2023 AT PUBLICATION OF ITS HALF YEAR RESULTS ON 2 AUGUST 2023 AS OF 28 APRIL 2023, DSM-FIRMENICH AG HOLDS 96.1% OF ORDINARY SHARES IN DSM N.V.
D
Reuters - Há 5 meses

DSM Agrees Terms To Acquire Postbiotics Pioneer Adare Biome

BRIEF-DSM Agrees Terms To Acquire Postbiotics Pioneer Adare Biome April 19 (Reuters) - Koninklijke DSM NV DSMN.AS : DSM AGREES TERMS TO ACQUIRE POSTBIOTICS PIONEER ADARE BIOME THIS TRANSACTION REPRESENTS AN ESTIMATED 2023 EV/EBITDA MULTIPLE OF 18X DEAL FOR AN ENTERPRISE VALUE OF EUR 275 MILLION DSM ANTICIPATES BEING ABLE TO RAPIDLY EXTEND AVAILABIL
D
Reuters - Há 5 meses

: Final Number Of DSM Firmenich Shares Admitted To Trading At 150,742,711 - Euronext

BRIEF-: Final Number Of DSM Firmenich Shares Admitted To Trading At 150,742,711 - Euronext April 18 (Reuters) - EURONEXT: FINAL NUMBER OF SHARES ADMITTED TO TRADING FOR DSM FIRMENICH AG AMOUNTS 150,742,711 Further company coverage: DSMN.AS (Gdansk Newsroom)
D
Reuters - Há 6 meses

Euronext Says Technical Reference Price For DSM Firmenich Is EUR 135.15/Shr

BRIEF-Euronext Says Technical Reference Price For DSM Firmenich Is EUR 135.15/Shr April 17 (Reuters) - EURONEXT: TECHNICAL REFERENCE PRICE FOR DSM FIRMENICH AG FOR OPENING TRADING SESSION ON 18/04/2023 IS EUR 135.15 PER SHARE - EURONEXT Further company coverage: DSMN.AS (Gdansk Newsroom)
D
Reuters - Há 6 meses

DSM, Firmenich Obtain All Competition Clearances From Competition Commission Of India

BRIEF-DSM, Firmenich Obtain All Competition Clearances From Competition Commission Of India April 4 (Reuters) - Koninklijke DSM NV DSMN.AS : DSM AND FIRMENICH HAVE OBTAINED ALL COMPETITION CLEARANCES DSM, FIRMENICH JOINTLY ANNOUNCE THAT THEY HAVE OBTAINED COMPETITION CLEARANCE FROM COMPETITION COMMISSION OF INDIA (CCI) ON 3 APRIL 2023 ACCEPTANCE PE
D
Reuters - Há 6 meses

DSM Completes Sale Of Engineering Materials Business For EUR 3.85 Bln Enterprise Value

BRIEF-DSM Completes Sale Of Engineering Materials Business For EUR 3.85 Bln Enterprise Value April 3 (Reuters) - Koninklijke DSM NV DSMN.AS : DSM COMPLETES SALE OF ENGINEERING MATERIALS BUSINESS ANNOUNCES COMPLETION OF SALE OF ITS ENGINEERING MATERIALS BUSINESS TO ADVENT INTERNATIONAL AND LANXESS FOR AN ENTERPRISE VALUE OF EUR 3.85 BILLION DSM WILL
D
L
Reuters - Há 6 meses

DSM: Acceptance Period Extended Pending Indian Competition Clearance Until No Later Than 12 May 2023

BRIEF-DSM: Acceptance Period Extended Pending Indian Competition Clearance Until No Later Than 12 May 2023 March 31 (Reuters) - Koninklijke DSM NV DSMN.AS : ACCEPTANCE PERIOD EXTENDED PENDING INDIAN COMPETITION CLEARANCE UNTIL NO LATER THAN 12 MAY 2023 ACCEPTANCE PERIOD IS HEREBY FURTHER EXTENDED UNTIL TWO WEEKS AFTER CLEARANCE IS OBTAINED, BUT NO
D
Reuters - Há 6 meses

War on cow farts is stinky but necessary job

BREAKINGVIEWS-War on cow farts is stinky but necessary job The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Karen Kwok LONDON, March 24 (Reuters Breakingviews) - Targeting cows to fight climate change may seem counterintuitive. Yet, governments from New Zealand to Europe are zeroing in on livestock, whose burps and farts help generate 15% of global greenhouse gas emissions each year, United Nations estimates show.
D
D
Reuters - Há 7 meses

Givaudan, Symrise, DSM shares drop on global fragrance cartel probe

UPDATE 4-Givaudan, Symrise, DSM shares drop on global fragrance cartel probe Givaudan, Symrise, IFF, Firmenich named in Swiss cartel probe Shares in companies drop by more than 2%, underperforming market Switzerland joins EU, UK, U.S. investigations Adds analyst, Firmenich comments By Ludwig Burger and John Stonestreet March 8 (Reuters) - Shares in Givaudan GIVN.S and Symrise SY1G.DE took a beating on Wednesday after the Swiss antitrust agency named them as part of a quartet of companies in the
D
G
H
K
S
I
P
Reuters - Há 7 meses

DSM And Firmenich Have Obtained Competition Clearance From European Commission

BRIEF-DSM And Firmenich Have Obtained Competition Clearance From European Commission Feb 23 (Reuters) - Koninklijke DSM NV DSMN.AS : DSM AND FIRMENICH HAVE OBTAINED COMPETITION CLEARANCE FROM EUROPEAN COMMISSION Source text for Eikon: ID:nPrecFYJta Further company coverage: DSMN.AS (Gdansk Newsroom)
D
Reuters - Há 8 meses

DSM Reports FY 2022 Net Profit Of Eur 1,715 Mln

BRIEF-DSM Reports FY 2022 Net Profit Of Eur 1,715 Mln Feb 16 (Reuters) - Dsm DSMN.AS : REPORTS 2022 RESULTS 2022 NET PROFIT OF EUR 1,715M, INCLUDING GAIN ON DISPOSAL OF DSM PROTECTIVE MATERIALS FY ADJUSTED NET OPERATING FREE CASH FLOW OF EUR 310M DSM-FIRMENICH WILL PROVIDE AN OUTLOOK FOR 2023 ONCE DSM AND FIRMENICH HAVE BEEN CONSOLIDATED AND COMBINED BUSINESS PLAN IS APPROVED AN INTERIM DIVIDEND FOR YEAR 2022 OF EUR 0.93 PER ORDINARY SHARE WAS RECOGNIZED AS A LIABILITY IN Q2 OF 2022. FY SALES EU
D
Reuters - Há 8 meses

Chemicals group DSM's sales meet expectations helped by price hikes

UPDATE 1-Chemicals group DSM's sales meet expectations helped by price hikes Adds management quotes, details about merger with Firmenich Feb 16 (Reuters) - DSM DSMN.AS on Thursday reported annual sales roughly in line with expectations as the Dutch specialty chemicals maker kept hiking prices to counter higher costs. "The fourth quarter saw overall continued resilient demand but also high raw materials costs, lower prices of some vitamins and customer de-stocking.
D
Reuters - Há 8 meses

DSM posts annual sales in line with expectations

DSM posts annual sales in line with expectations Feb 16 (Reuters) - DSM DSMN.AS on Thursday reported annual sales roughly in line with expectations as the Dutch specialty chemicals maker kept hiking prices to counter higher costs. The group reported 2022 sales of 8.39 billion euros ($8.98 billion) from continuing operations, against analysts' estimate of 8.41 billion euros in a poll compiled by Vara Research.
D
Reuters - Há 8 meses

DSM Shareholders Approve Firmenich Merger At EGM

BRIEF-DSM Shareholders Approve DSM-Firmenich Merger At EGM Jan 23 (Reuters) - Koninklijke DSM NV DSMN.AS : DSM SHAREHOLDERS APPROVE DSM-FIRMENICH MERGER AT EXTRAORDINARY GENERAL MEETING Source text for Eikon: ID:nPrenh9Wna Further company coverage: DSMN.AS (Gdansk Newsroom)
D
Reuters - Há 8 meses

DSM: Acceptance Period For Exchange Offer Extended Pending Competition Clearances

BRIEF-DSM: Acceptance Period For Exchange Offer Extended Pending Competition Clearances Jan 23 (Reuters) - Koninklijke DSM NV DSMN.AS : ACCEPTANCE PERIOD FOR EXCHANGE OFFER EXTENDED PENDING COMPETITION CLEARANCES ACCEPTANCE PERIOD DURING WHICH DSM SHAREHOLDERS CAN TENDER THEIR DSM ORDINARY SHARES INTO THE EXCHANGE OFFER THAT LAUNCHED ON 22 NOVEMBER
D

Condições

Ativos populares

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Usamos cookies para lhe dar a melhor experiência no nosso website. Ler mais ou alterar as configurações de cookies.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.